ActiGraph, LLC

Ametris (formerly ActiGraph) is a digital health technology (DHT) company specializing in wearable medical devices and remote monitoring platforms for clinical research and drug development. The company provides FDA-cleared, medical-grade wearable devices paired with a scalable remote monitoring platform to capture objective, real-world patient data across multiple clinical domains. Ametris delivers an integrated, end-to-end solution combining hardware, cloud-based software, proprietary algorithms, and comprehensive operational and scientific support services. Core measurement capabilities include physical activity, gait and mobility analysis, sleep behavior monitoring, vital signs tracking, and cardinal symptom assessment. The platform is purpose-built to support all phases of the clinical trial lifecycle—from study design and site training to data collection, processing, archiving, and real-time monitoring. Ametris has established expertise in neuromuscular disorders, oncology, neuroscience, sleep medicine, and metabolic diseases. The company serves pharmaceutical sponsors, biotechnology firms, clinical research organizations (CROs), academic institutions, and hospital research networks across 150+ countries. With over 20 years of remote data capture expertise, 30,000+ peer-reviewed scientific publications supporting its technologies, and operational involvement in 285+ industry-sponsored clinical trials, Ametris positions itself as a scientific partner rather than a technology vendor alone. Services include endpoint design consultation, algorithm validation, regulatory strategy support, and DHT data interpretation. The company maintains headquarters in Pensacola, Florida, and operates a global support infrastructure with 24-hour critical support availability.